AzTrials
AzTrials

Depression Anxiety DisorderNCT05963308

Promoting Sustainable Return to Work Among Employees on Sick Leave Due to a Mental Health Condition: Evaluation of the HealthyMinds Online Group Intervention

A study testing Healthy Minds in people with Depression Anxiety Disorder and Adjustment Disorders, run by Université du Québec a Montréal at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this clinical trial is to evaluate the impact of an online group intervention called Healthy Minds in facilitating a sustainable return to work for individuals with a mood disorder. Read more about this study

Who is it for?
Ages 18 to 60 years
What is being tested?
Healthy Minds
Could I receive a placebo?
No, everyone receives an active treatment
How many people
123 participants
Where
1 siteCanada
Study dates
6 Mar 2023to 1 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Be in the process of returning to work after depression, anxiety disorder, adjustment disorder (with depressed mood, or anxious mood).
  • or
  • Been back for less than a month

Who cannot join

  • Inability to communicate in French
  • Have a known organic disorder
  • Have already received CBT-type intervention (group or individual)

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Université du Québec à Montréal

    Montreal, Quebec, H3C 3P8

Other trials in Canada

About this study

The purpose of this clinical trial is to evaluate the impact of an online group intervention called Healthy Minds in facilitating a sustainable return to work for individuals with a mood disorder. The study aims to answer the following key questions :

  • Does receiving the Healthy Minds online intervention lead to a more sustainable return to work compared to not receiving the intervention?
  • Are the health outcomes (e.g., depressive symptoms) and work-related outcomes (e.g., work functioning) of individuals who receive the Healthy Minds online intervention better than those who do not receive the intervention in the year following the intervention?
Read more

Both experimental and control participants will be recruited at baseline while on sick leave (expected to return to work in less than one month) or recently returned to work (less than one month). Participants will complete a series of online questionnaires at the following time points :

  • Baseline
  • First follow-up (2 months after baseline)
  • Second follow-up (6 months after baseline)
  • Third follow-up (12 months after baseline)

The questionnaires will cover the following areas :

  • Sociodemographic and biopsychosocial factors
  • Symptoms associated with the primary mood disorder
  • Cognitive difficulties and biaises
  • Self-efficacy related to return to work
  • Work accommodations and natural supports
  • Relationship with immediate supervisor
  • Work functioning
  • Return to work time (number of days away from work)

Experimental participants will participate in the 2-month online Healthy Minds group intervention (cohort of 5 participants) between the baseline assessment and the first follow-up. The intervention consists of 8 sessions (one per week for 8 weeks), with each session focusing on a specific aspect of the return-to-work process from a cognitive-behavioral perspective.

Being tested
Healthy Minds
Medical subject headings
Adjustment Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Healthy MindsBehavioural

    The group intervention (approximately 5 participants per group, 8 groups) is facilitated by two clinicians and consists of 8 sessions (one per week for 8 weeks), with each session focusing on a specific aspect of the return-to-work process from a cognitive-behavioral perspective:

    Week1: Coping with work stress at work W2 and W3: Recognizing and modifying my dysfunctional beliefs linked to work W4: Overcoming obstacles linked to work functioning and maintaining work W5: To put in place needed work accommodations with the support of the immediate supervisor W6: My strengths and competencies related to work W7: Accepting criticism and asserting myself appropriately W7: My strengths and related skills W8: My best coping strategies for work Both intervention and control participants receive their standard individualized care from their clinician. However, for the experimental participants, the Healthy Minds intervention is an added component to their regular care.

Study groups in NCT05963308
Study groupRoleWhat they receive
Online group intervention "Healthy Minds"ExperimentalNot described
Receives: Behavioral: Healthy Minds
Control groupNo interventionLike the intervention group, the control group will complete an online set of questionnaires at the following time points: * Baseline * First follow-up (2 months after baseline) * Second follow-up (6 months after baseline) * Third follow-up (12 months after baseline) The questionnaires will cover the following domains: * Sociodemographic and biopsychosocial factors * Symptoms associated with the primary mood disorder * Cognitive difficulties and distortions * Self-efficacy in relation to returning to work * Work accommodations and natural supports * Relationship with immediate supervisor * Work functioning * Return-to-work time (number of days away from work)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sustainable return-to-work

    The number of days of job retention after returning to work

    Measured: Baseline; follow-ups at six months and 12 months

  2. Depressive symptoms

    Patient Health Questionnaire for depression (PHQ-9)

    Measured: Baseline; follow-ups at two months, six months and 12 months

  3. Anxiety symptoms

    Generalized Anxiety Disorder Scale (GAD-7)

    Measured: Baseline ; follow-ups at two months, six months and 12 months

  4. Work functioning

    Endicott Work Productivity Scale (EWPS)

    Measured: Follow-ups at six months and 12 months

  5. Relationship with immediate supervisor

    Inventory of perceptions of supervisory style at work

    Measured: Follow-ups at six months and 12 months

  6. Work accommodations

    The Work Accommodation and Natural Support Scale (WANSS).

    Measured: Follow-ups at six months and 12 months

  7. Return to Work Obstacles and Self-Efficacy

    Return to Work Obstacles and Self-Efficacy Scale (ROSES)

    Measured: Baseline ; Follow-ups at two months

  8. Cognitive difficulties

    Online Stroop test (French version)

    Measured: Baseline ; Follow-ups at two months, six months and 12 months

  9. Cognitive biases

    Davos Assessment of the Cognitive Biases Scale

    Measured: Baseline ; Follow-ups at two months, six months and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2023
  2. Study start6 Mar 2023
  3. Primary completion1 Mar 2026
  4. Study completion1 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
123 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05963308
Sponsor's protocol ID
2023-0SYA-316461
Status last verified
May 2026
First submitted
18 Jul 2023
Last updated
1 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Healthy Minds in people with Depression Anxiety Disorder and Adjustment Disorders, run by Université du Québec a Montréal at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sustainable return-to-work (time frame: Baseline; follow-ups at six months and 12 months). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in